Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B cells in GVHD: friend or foe?
Davis JE, Ritchie DS. Davis JE, et al. Among authors: ritchie ds. Blood. 2010 Mar 25;115(12):2558-9; author reply 2559-60. doi: 10.1182/blood-2009-11-254177. Blood. 2010. PMID: 20339111 Free article. No abstract available.
Allogeneic transplantation as anticancer immunotherapy.
Parmar S, Ritchie DS. Parmar S, et al. Among authors: ritchie ds. Curr Opin Immunol. 2014 Apr;27:38-45. doi: 10.1016/j.coi.2014.01.010. Epub 2014 Feb 15. Curr Opin Immunol. 2014. PMID: 24534447 Review.
A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE, Harvey M, Gherardin NA, Koldej R, Huntington N, Neeson P, Trapani JA, Ritchie DS. Davis JE, et al. Among authors: ritchie ds. Biol Blood Marrow Transplant. 2015 Feb;21(2):242-9. doi: 10.1016/j.bbmt.2014.11.003. Epub 2014 Nov 12. Biol Blood Marrow Transplant. 2015. PMID: 25459639 Free article.
MicroRNA as potential biomarkers in Glioblastoma.
Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, Morokoff AP, Kaye AH, Luwor RB. Areeb Z, et al. Among authors: ritchie ds. J Neurooncol. 2015 Nov;125(2):237-48. doi: 10.1007/s11060-015-1912-0. Epub 2015 Sep 21. J Neurooncol. 2015. PMID: 26391593 Review.
Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.
Neeson PJ, Hsu AK, Chen YR, Halse HM, Loh J, Cordy R, Fielding K, Davis J, Noske J, Davenport AJ, Lindqvist-Gigg CA, Humphreys R, Tai T, Prince HM, Trapani JA, Smyth MJ, Ritchie DS. Neeson PJ, et al. Among authors: ritchie ds. Oncoimmunology. 2015 May 27;4(9):e1038011. doi: 10.1080/2162402X.2015.1038011. eCollection 2015 Sep. Oncoimmunology. 2015. PMID: 26405606 Free PMC article.
Practical management of myelofibrosis with ruxolitinib.
Ho PJ, Marlton P, Tam C, Stevenson W, Ritchie D, Bird R, Dunlop LC, Durrant S, Ross DM. Ho PJ, et al. Intern Med J. 2015 Dec;45(12):1221-30. doi: 10.1111/imj.12921. Intern Med J. 2015. PMID: 26648193 Review.
236 results